Quest Diagnostics (DGX) Tops Q3 Views; Raises FY09 Outlook
DGX Hot Sheet
EPS Growth %: +7.0%Financial Fact:
Total operating costs and expenses: 1.64B
Today's EPS Names:
TARO, BRLI, TLB, More
Quest Diagnostics Inc. (NYSE: DGX) reports Q3 EPS of $1.02, 6 cents better than the analyst estimate of $0.96. Revenue for the quarter was $1.9 billion, which compares to the estimate of $1.89 billion.
Raises its FY09 EPS guidance from $3.70-$3.80 to $3.80-$3.85. The Street is currently looking for EPS of $3.79.
Raises its FY09 EPS guidance from $3.70-$3.80 to $3.80-$3.85. The Street is currently looking for EPS of $3.79.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Signet Jewelers (SIG) Tops Q1 EPS by 5c; Guides Q2 Below the Street
- Jiayuan.com (DATE) Reports In-Line Q1 EPS of 5c; Guides Q2 Revs
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
